Fiona McCartney
Cited by
Cited by
Safety concerns over the use of intestinal permeation enhancers: A mini-review
F McCartney, JP Gleeson, DJ Brayden
Tissue barriers 4 (2), e1176822, 2016
Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies
F McCartney, V Jannin, S Chevrier, H Boulghobra, DR Hristov, N Ritter, ...
Journal of Controlled Release 310, 115-126, 2019
Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin
E Presas, F McCartney, E Sultan, C Hunger, S Nellen, CV Alvarez, ...
Journal of controlled release 286, 402-414, 2018
Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae
S Maher, J Heade, F McCartney, S Waters, SB Bleiel, DJ Brayden
International journal of pharmaceutics 539 (1-2), 11-22, 2018
Evaluation of sucrose laurate as an intestinal permeation enhancer for macromolecules: ex vivo and in vivo studies
F McCartney, M Rosa, DJ Brayden
Pharmaceutics 11 (11), 565, 2019
Silica-Coated Nanoparticles with a Core of Zinc, l-Arginine, and a Peptide Designed for Oral Delivery
D Hristov, F McCartney, J Beirne, E Mahon, S Reid, S Bhattacharjee, ...
ACS applied materials & interfaces 12 (1), 1257-1269, 2019
Striving towards the perfect in vitro oral drug absorption model
JP Gleeson, F McCartney
Trends in pharmacological sciences 40 (10), 720-724, 2019
An enteric-coated polyelectrolyte nanocomplex delivers insulin in rat intestinal instillations when combined with a permeation enhancer
S Sladek, F McCartney, M Eskander, DJ Dunne, MJ Santos-Martinez, ...
Pharmaceutics 12 (3), 259, 2020
The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond–a report
V Stuttgen, HE Giffney, A Anandan, A Alabdali, C Twarog, SA Belhout, ...
Nanotoxicology 13 (6), 717-732, 2019
Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C10): Isolated rat intestinal mucosae and sacs
C Twarog, F McCartney, SM Harrison, B Illel, E Fattal, DJ Brayden
European Journal of Pharmaceutical Sciences 158, 105685, 2021
Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System
J Heade, F McCartney, M Chenlo, OM Marro, M Severic, R Kent, SB Bleiel, ...
Pharmaceutics 13 (5), 656, 2021
Insulin-containing silica nanoparticles with a high loading capacity and demonstration of bioactivity: potential for oral delivery
D Hristov, F McCartney, J Beirne, S Reid, E Mahon, S Bhattacharjee, ...
Cystic ovary disease impairs transport speed, smooth muscle contraction, and epithelial ion transport in the bovine oviduct
DM Scully, D Campion, F McCartney, K Dulohery, S Reese, S Kölle
Molecular Reproduction and Development 88 (8), 558-570, 2021
Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae
F McCartney, DR Perinelli, M Tiboni, R Cavanagh, S Lucarini, GF Palmieri, ...
International Journal of Pharmaceutics 601, 120593, 2021
5 Transport and cholinergic innervation in the bovine oviduct are dysregulated in cystic ovary disease
D Scully, D Campion, F McCartney, S Reese, S Kölle
Reproduction, Fertility and Development 32 (2), 127-127, 2020
A cell penetrating peptide-medium chain fatty acid conjugate increases paracellular permeability across isolated rat intestinal mucosae
F McCartney, J Garcia, M Teixido, J Heade, E Giralt, DJ Brayden
Investigation of the cytotoxicity of a sucrose laurate, a novel intestinal permeation enhancer
F McCartney, M Rosa, DJ Brayden
Synthesis of hyaluronic acid-based nanoparticles for oral insulin delivery
P Rooney, A Srivastava, J Gleeson, F McCartney, A Pandit, DJ Brayden
The system can't perform the operation now. Try again later.
Articles 1–18